AUD 0.1
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 | 16.64 Million AUD | -28.94% |
2023 | 23.42 Million AUD | 46.57% |
2022 | 15.98 Million AUD | 64.02% |
2021 | 9.74 Million AUD | 22.54% |
2020 | 7.95 Million AUD | 12.55% |
2019 | 7.06 Million AUD | 14.32% |
2018 | 6.18 Million AUD | -21.12% |
2017 | 7.83 Million AUD | -16.99% |
2016 | 9.44 Million AUD | 25.12% |
2015 | 7.54 Million AUD | 3.21% |
2014 | 7.31 Million AUD | 4.26% |
2013 | 7.01 Million AUD | -15.44% |
2012 | 8.29 Million AUD | -8.47% |
2011 | 9.06 Million AUD | -10.47% |
2010 | 10.12 Million AUD | -18.01% |
2009 | 12.34 Million AUD | 27.96% |
2008 | 9.64 Million AUD | -6.34% |
2007 | 10.3 Million AUD | 34.82% |
2006 | 7.64 Million AUD | 36.04% |
2005 | 5.61 Million AUD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q3 | 4.18 Million AUD | 20.08% |
2024 Q4 | 4.18 Million AUD | 0.0% |
2024 Q2 | 3.48 Million AUD | -20.45% |
2024 FY | 6.87 Million AUD | -70.64% |
2024 Q1 | 4.38 Million AUD | 57.91% |
2023 FY | 23.42 Million AUD | 46.57% |
2023 Q4 | 2.77 Million AUD | -58.2% |
2023 Q2 | 4.69 Million AUD | -8.43% |
2023 Q1 | 5.12 Million AUD | 54.23% |
2023 Q3 | 6.63 Million AUD | 41.41% |
2022 FY | 15.98 Million AUD | 64.02% |
2022 Q4 | 3.32 Million AUD | -8.61% |
2022 Q3 | 3.63 Million AUD | 35.97% |
2022 Q2 | 2.67 Million AUD | -36.88% |
2022 Q1 | 4.23 Million AUD | 187.54% |
2021 Q2 | 1.46 Million AUD | -35.29% |
2021 Q1 | 2.25 Million AUD | -36.24% |
2021 Q4 | 1.47 Million AUD | -44.3% |
2021 Q3 | 2.64 Million AUD | 81.01% |
2021 FY | 9.74 Million AUD | 22.54% |
2020 Q2 | 4.2 Million AUD | 103.07% |
2020 FY | 7.95 Million AUD | 12.55% |
2020 Q4 | 3.54 Million AUD | 107.28% |
2020 Q3 | 1.7 Million AUD | -59.37% |
2020 Q1 | 2.07 Million AUD | -46.87% |
2019 Q2 | 1.66 Million AUD | -0.0% |
2019 Q4 | 3.89 Million AUD | 127.79% |
2019 FY | 7.06 Million AUD | 14.32% |
2019 Q1 | 1.66 Million AUD | -22.69% |
2019 Q3 | 1.71 Million AUD | 2.6% |
2018 Q4 | 2.15 Million AUD | 0.0% |
2018 Q3 | 2.15 Million AUD | 43.44% |
2018 FY | 6.18 Million AUD | -21.12% |
2018 Q2 | 1.5 Million AUD | -0.0% |
2018 Q1 | 1.5 Million AUD | -38.71% |
2017 FY | 7.83 Million AUD | -16.99% |
2017 Q2 | 1.61 Million AUD | -0.0% |
2017 Q1 | 1.61 Million AUD | -37.55% |
2017 Q4 | 2.45 Million AUD | 0.0% |
2017 Q3 | 2.45 Million AUD | 51.56% |
2016 Q3 | 2.59 Million AUD | 45.33% |
2016 Q4 | 2.59 Million AUD | 0.0% |
2016 Q2 | 1.78 Million AUD | 0.0% |
2016 Q1 | 1.78 Million AUD | -1.56% |
2016 FY | 9.44 Million AUD | 25.12% |
2015 FY | 7.54 Million AUD | 3.21% |
2015 Q4 | 1.81 Million AUD | 0.0% |
2015 Q3 | 1.81 Million AUD | 52.53% |
2015 Q2 | 1.18 Million AUD | 0.0% |
2015 Q1 | 1.18 Million AUD | -34.43% |
2014 Q4 | 1.81 Million AUD | 0.0% |
2014 Q1 | 1.57 Million AUD | 21.35% |
2014 FY | 7.31 Million AUD | 4.26% |
2014 Q2 | 1.57 Million AUD | -0.0% |
2014 Q3 | 1.81 Million AUD | 14.81% |
2013 Q3 | 1.3 Million AUD | 3.69% |
2013 Q2 | 1.25 Million AUD | 0.0% |
2013 Q4 | 1.3 Million AUD | 0.0% |
2013 FY | 7.01 Million AUD | -15.44% |
2013 Q1 | 1.25 Million AUD | -38.13% |
2012 Q2 | 2.02 Million AUD | -10.49% |
2012 Q4 | 2.02 Million AUD | 0.0% |
2012 Q3 | 2.02 Million AUD | 0.0% |
2012 Q1 | 2.26 Million AUD | 0.0% |
2012 FY | 8.29 Million AUD | -8.47% |
2011 Q1 | 2.53 Million AUD | 0.0% |
2011 Q4 | 2.26 Million AUD | 0.0% |
2011 FY | 9.06 Million AUD | -10.47% |
2011 Q3 | 2.26 Million AUD | 0.0% |
2011 Q2 | 2.26 Million AUD | -10.47% |
2010 Q2 | 2.53 Million AUD | -18.01% |
2010 Q3 | 2.53 Million AUD | 0.0% |
2010 Q1 | 3.08 Million AUD | 0.0% |
2010 FY | 10.12 Million AUD | -18.01% |
2010 Q4 | 2.53 Million AUD | 0.0% |
2009 Q2 | 3.08 Million AUD | 27.96% |
2009 Q4 | 3.08 Million AUD | 0.0% |
2009 Q1 | 2.41 Million AUD | 0.0% |
2009 Q3 | 3.08 Million AUD | 0.0% |
2009 FY | 12.34 Million AUD | 27.96% |
2008 Q1 | 422.5 Thousand AUD | 0.0% |
2008 Q2 | 2.41 Million AUD | 470.82% |
2008 Q3 | 2.41 Million AUD | 0.0% |
2008 FY | 9.64 Million AUD | -6.34% |
2008 Q4 | 2.41 Million AUD | 0.0% |
2007 Q2 | 422.5 Thousand AUD | 74.05% |
2007 Q3 | 422.5 Thousand AUD | 0.0% |
2007 Q4 | 422.5 Thousand AUD | 0.0% |
2007 FY | 10.3 Million AUD | 34.82% |
2007 Q1 | 242.75 Thousand AUD | 0.0% |
2006 Q3 | 242.75 Thousand AUD | 0.0% |
2006 Q1 | 241.25 Thousand AUD | 0.0% |
2006 FY | 7.64 Million AUD | 36.04% |
2006 Q2 | 242.75 Thousand AUD | 0.62% |
2006 Q4 | 242.75 Thousand AUD | 0.0% |
2005 Q4 | 241.25 Thousand AUD | 0.0% |
2005 Q2 | 241.25 Thousand AUD | 0.0% |
2005 FY | 5.61 Million AUD | 0.0% |
2005 Q3 | 241.25 Thousand AUD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
4DMedical Limited | 31.48 Million AUD | 47.119% |
Adherium Limited | 267.7 Thousand AUD | -6119.196% |
Aroa Biosurgery Limited | 66.09 Million AUD | 74.812% |
Atomo Diagnostics Limited | 1.6 Million AUD | -936.671% |
Anteris Technologies Ltd | 69.14 Million AUD | 75.923% |
Control Bionics Limited | 9.82 Million AUD | -69.439% |
Compumedics Limited | 26.88 Million AUD | 38.062% |
Cochlear Limited | 1.17 Billion AUD | 98.583% |
CleanSpace Holdings Limited | 11.35 Million AUD | -46.567% |
Cyclopharm Limited | 13.38 Million AUD | -24.424% |
EMVision Medical Devices Ltd | 12.83 Million AUD | -29.729% |
Nova Eye Medical Limited | 23.99 Million AUD | 30.6% |
HeraMED Limited | 6.78 Million AUD | -145.453% |
Imricor Medical Systems, Inc. | -1.11 Million AUD | 1592.059% |
ImpediMed Limited | 28.04 Million AUD | 40.626% |
InhaleRx Limited | 2.59 Million AUD | -542.685% |
LBT Innovations Limited | 1.1 Million AUD | -1403.972% |
Micro-X Limited | 18.76 Million AUD | 11.272% |
Neurotech International Limited | 8.75 Million AUD | -90.181% |
OncoSil Medical Limited | 12.03 Million AUD | -38.282% |
PolyNovo Limited | 34.92 Million AUD | 52.325% |
Respiri Limited | 8.03 Million AUD | -107.209% |
SomnoMed Limited | 58.97 Million AUD | 71.768% |
Universal Biosensors, Inc. | 20 Million AUD | 16.756% |
Uscom Limited | 5.52 Million AUD | -201.609% |
Visioneering Technologies, Inc. | 9.63 Million AUD | -72.821% |